Phase 3 efficacy analysis of a typhoid conjugate vaccine trial in Nepal
<p><strong>BACKGROUND</strong></p> <p>Salmonella Typhi is a major cause of fever in children in low- and middle-income countries. A typhoid conjugate vaccine (TCV) that was recently prequalified by the World Health Organization was shown to be efficacious in a human cha...
Main Authors: | Shakya, M, Colin-Jones, R, Theiss-Nyland, K, Voysey, M, Pant, D, Smith, N, Liu, X, Tonks, S, Mazur, O, Farooq, YG, Clarke, J, Hill, J, Adhikari, A, Dongol, S, Karkey, A, Bajracharya, B, Kelly, S, Gurung, M, Baker, S, Neuzil, KM, Shrestha, S, Basnyat, B, Pollard, AJ, Tyvac Nepal Study Team |
---|---|
Format: | Journal article |
Language: | English |
Published: |
Massachusetts Medical Society
2019
|
Similar Items
-
Phase 3 efficacy analysis of a typhoid conjugate vaccine trial in Nepal
by: Shakya, M, et al.
Published: (2019) -
Logistics of implementing a large-scale typhoid vaccine trial in Kathmandu, Nepal
by: Colin-Jones, R, et al.
Published: (2019) -
Assessing the impact of a vi-polysaccharide conjugate vaccine in preventing typhoid infections among Nepalese children: a protocol for a phase III, randomized control trial
by: Theiss-Nyland, K, et al.
Published: (2019) -
Public engagement during a typhoid conjugate vaccine trial in Lalitpur, Nepal- experience, challenges and lessons learnt
by: Dahal, A, et al.
Published: (2022) -
Efficacy of typhoid conjugate vaccine in Nepal: final results of a phase 3, randomised, controlled trial
by: Shakya, M, et al.
Published: (2021)